LITHOSUN 300

1. All Details: Specifications
Dosage Form: Uncoated tablets.
Storage Conditions: Store at room temperature, protected from light and moisture.
Manufacturing License Number: M.L.: 374/DR/Mfg/2013 (partially obscured by print but legible across sections).
Product Coding Identifier: PESPF0220.
Physical Tablet Appearance: Round, white, uncoated solid oral tablets visible through the semi-transparent blister pockets.
Batch / Expiry Data: Not fully visible or stamp-printed on this specific side of the foil strip.
2. General
Brand: LITHOSUN® 300
Generic Name: Lithium Carbonate Tablets IP
Quantity: Standard strip format (typically 10 or 15 tablets; 10 individual tablet pockets are visible on this portion of the blister strip).
Type: Allopathic Pharmaceutical / Prescription Drug (indicated by the “Rx” symbol and the red statutory Schedule H prescription caution box).
Form Factor: Blister strip containing solid oral tablets.
Maximum Shelf Life: Not explicitly stated on this section of the packaging foil.
Food Preference / FSSAI: Not Applicable. This is a therapeutic psychiatric medication used under medical guidance, not a commercial food product or dietary supplement. It falls under the regulatory purview of national drug control authorities instead of the FSSAI food authority, and it does not display vegetarian or non-vegetarian symbols.
3. Product Details: Ingredients
Each uncoated tablet contains:
Lithium Carbonate IP: 300 mg
Excipients: q.s. (Quantity Sufficient)
4. Directions: How to Use
Dosage: As directed by the Physician.
Statutory Warning Label:
SCHEDULE H PRESCRIPTION DRUG – CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
5. Description
Therapeutic Application: LITHOSUN® 300 is an immediate-release oral psychiatric prescription medication containing 300 mg of Lithium Carbonate. Lithium is a foundational mood stabilizer primarily utilized under strict clinical supervision for the management of manic episodes associated with bipolar disorder, as well as for long-term maintenance therapy to prevent or decrease the intensity of subsequent manic or depressive relapses.
Visual Presentation: The product is enclosed in a protective textured silver aluminum foil blister strip designed to insulate the tablets from light and environmental humidity. The packaging features prominent green blocks with white text highlighting the “LITHOSUN® 300” brand name, a repeating blue sidebar pattern, standard black text detailing formulation specifics, a solid red warning block for safety protocol, and a small inventory barcode.
6. Manufacturer Information
Manufactured in India by: sun pharma laboratories ltd.
Factory Address: Vill: Kokjhar, Mirza Palashbari Road, P.O.: Palashbari, Dist: Kamrup, Assam-781128.
7. Marketed By
Marketed by: sun pharma laboratories ltd. .